Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Accumulated Expenses: 2011-2020

Historic Other Accumulated Expenses for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2020 value amounting to $17.8 million.

  • Neurocrine Biosciences' Other Accumulated Expenses rose 29.03% to $20.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $20.0 million, marking a year-over-year increase of 29.03%. This contributed to the annual value of $17.8 million for FY2020, which is 17.11% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Other Accumulated Expenses stood at $17.8 million for FY2020, which was up 17.11% from $15.2 million recorded in FY2019.
  • Neurocrine Biosciences' 5-year Other Accumulated Expenses high stood at $18.2 million for FY2017, and its period low was $1.9 million during FY2018.
  • Its 3-year average for Other Accumulated Expenses is $11.6 million, with a median of $15.2 million in 2019.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first slumped by 89.79% in 2018, then soared by 718.97% in 2019.
  • Over the past 5 years, Neurocrine Biosciences' Other Accumulated Expenses (Yearly) stood at $6.0 million in 2016, then surged by 203.12% to $18.2 million in 2017, then slumped by 89.79% to $1.9 million in 2018, then spiked by 718.97% to $15.2 million in 2019, then climbed by 17.11% to $17.8 million in 2020.